InsiderSignal.AI

InsiderSignal.ai

AMLX - Amylyx Pharmaceuticals, Inc.

Insider Sale by Mazzariello Gina (GC)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Mazzariello Gina, serving as GC at Amylyx Pharmaceuticals, Inc. (AMLX), sold 6,844 shares at $14.52 per share, for a total transaction value of $99,378.00. Following this transaction, Mazzariello Gina now holds 134,430 shares of AMLX.

This sale represents a 5.00% decrease in Mazzariello Gina's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Amylyx Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Mazzariello Gina

GC

Gina M. Mazzariello is the Chief Legal Officer and General Counsel at Amylyx Pharmaceuticals, a position she has held since February 2022[[1]](https://theorg.com/org/amylyx/org-chart/gina-m-mazzariello). She brings more than 20 years of experience in the healthcare industry, with a deep expertise in pharmaceutical development, commercialization, and regulatory affairs[[1]](https://theorg.com/org/amylyx/org-chart/gina-m-mazzariello)[[3]](https://www.amylyx.com/news/amylyx-pharmaceuticals-expands-executive-team-with-appointment-of-gina-m-mazzariello-as-chief-legal-officer-and-general-counsel). Mazzariello earned her Bachelor's degree in Management from Syracuse University and her J.D. from Harvard Law School[[1]](https://theorg.com/org/amylyx/org-chart/gina-m-mazzariello). Prior to joining Amylyx, Mazzariello spent nearly 15 years at Boehringer Ingelheim USA, Inc., where she held positions of increasing responsibility in legal leadership[[3]](https://www.amylyx.com/news/amylyx-pharmaceuticals-expands-executive-team-with-appointment-of-gina-m-mazzariello-as-chief-legal-officer-and-general-counsel). Most recently, she served as Vice President of Human Pharma Business Law, where she led a team of lawyers and paraprofessionals providing legal counsel and strategic support across research, clinical development, and commercial operations for the company's U.S. prescription pharmaceuticals business[[1]](https://theorg.com/org/amylyx/org-chart/gina-m-mazzariello). Before Boehringer Ingelheim, she served as in-house counsel for GlaxoSmithKline and worked in private practice representing healthcare providers, health systems, and pharmaceutical companies[[3]](https://www.amylyx.com/news/amylyx-pharmaceuticals-expands-executive-team-with-appointment-of-gina-m-mazzariello-as-chief-legal-officer-and-general-counsel). Beyond her corporate roles, Mazzariello has demonstrated a strong commitment to diversity and inclusion, having served as President of the Board of Directors for the Lawyers Collaborative for Diversity, a non-profit organization focused on increasing diversity in the legal profession in Connecticut[[1]](https://theorg.com/org/amylyx/org-chart/gina-m-mazzariello).

View full insider profile →

Trade Price

$14.52

Quantity

6,844

Total Value

$99,378.00

Shares Owned

134,430

Trade Date

Monday, March 2, 2026

3 days ago

SEC Filing Date

Wednesday, March 4, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Amylyx Pharmaceuticals, Inc.

Company Overview

No company information available
View news mentioning AMLX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4496387

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime